Results 81 to 90 of about 18,081 (213)

Characterization of a quantitative method to measure free proprotein convertase subtilisin/kexin type 9 in human serum [PDF]

open access: gold, 2014
Alexander Colbert   +5 more
openalex   +1 more source

Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors

open access: yesInternational Journal of Biological Sciences, 2010
Proprotein convertases are enzymes that proteolytically cleave protein precursors in the secretory pathway to yield functional proteins. Seven mammalian subtilisin/Kex2p-like proprotein convertases have been identified: furin, PC1, PC2, PC4, PACE4, PC5 ...
Sun Tian, Wu Jianhua
doaj  

Image_3_Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Concentrations and Cardiovascular Events in Cardiovascular Disease: A Systemic Review and Meta-Analysis.TIF

open access: green, 2021
Jiahui Liu (724342)   +6 more
openalex   +2 more sources

Therapeutic Strategies for Hypercholesterolemia

open access: yeshealthbook TIMES Das Schweizer Ärztejournal Journal Des Médecins Suisses
A high cholesterol level in the blood is associated with an increased risk of atherosclerosis and its related conditions such as heart attack and stroke.
Georg Noll   +3 more
doaj   +1 more source

TACE/ADAM‐17 maturation and activation of sheddase activity require proprotein convertase activity [PDF]

open access: bronze, 2003
Nadim Srour   +6 more
openalex   +1 more source

Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis [PDF]

open access: bronze, 2020
Robert P. Giugliano   +12 more
openalex   +1 more source

Proprotein Convertase FURIN Constrains Th2 Differentiation and Is Critical for Host Resistance against Toxoplasma gondii [PDF]

open access: bronze, 2014
Anna Oksanen   +11 more
openalex   +1 more source

Increased Valency Improves Inhibitory Activity of Peptides Targeting Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

open access: green, 2021
Benjamin J. Tombling   +5 more
openalex   +2 more sources

The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis

open access: yesFrontiers in Neurology
ObjectiveTo investigate if cholesterol-lowering drugs exert effects on neurocognitive function.MethodsWe searched Pubmed, Embase and Cochrane Libarary from inception to March 23rd, 2023, and searched clinicaltrials.gov on January 23rd, 2024.
Kaiwei Li   +5 more
doaj   +1 more source

Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies [PDF]

open access: hybrid, 2018
Marie Duhamel   +13 more
openalex   +1 more source

Home - About - Disclaimer - Privacy